Skip to main content
NCBI home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1968 Jun;33(2):257–265. doi: 10.1111/j.1476-5381.1968.tb00987.x

Aspects of the biogenic amine-depleting activity of ethyl 3-acetamido-4H-pyrrolo-[3,4-c]isoxazole-5(6H)-carboxylate in the rat.

W Lippmann, M Wishnick
PMCID: PMC1570230  PMID: 5664146

Full text

PDF
257

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOGDANSKI D. F., PLETSCHER A., BRODIE B. B., UNDENFRIEND S. Identification and assay of serotonin in brain. J Pharmacol Exp Ther. 1956 May;117(1):82–88. [PubMed] [Google Scholar]
  2. CANNON P. J., WHITLOCK R. T., MORRIS R. C., ANGERS M., LARAGH J. H. Effect of alpha-methyl DOPA in severe and malignant hypertension. JAMA. 1962 Mar 3;179:673–681. doi: 10.1001/jama.1962.03050090001001. [DOI] [PubMed] [Google Scholar]
  3. CROUT J. R., MUSKUS A. J., TRENDELENBURG U. Effect of tyramine on isolated guinea-pig atria in relation to their noradrenaline stores. Br J Pharmacol Chemother. 1962 Jun;18:600–611. doi: 10.1111/j.1476-5381.1962.tb01179.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. GILLESPIE L., Jr, OATES J. A., CROUT J. R., SJOERDSMA A. Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension. Circulation. 1962 Feb;25:281–291. doi: 10.1161/01.cir.25.2.281. [DOI] [PubMed] [Google Scholar]
  5. HAFKENSCHIEL J. H., SELLERS A. M. Intravenous reserpine in patients with essential hypertension. Ann N Y Acad Sci. 1954 Apr 30;59(1):54–60. doi: 10.1111/j.1749-6632.1954.tb45918.x. [DOI] [PubMed] [Google Scholar]
  6. HESS S. M., CONNAMACHER R. H., OZAKI M., UDENFRIEND S. The effects of alpha-methyl-DOPA and alpha-methyl-metatyrosine on the metabolism of norepinephrine and serotonin in vivo. J Pharmacol Exp Ther. 1961 Nov;134:129–138. [PubMed] [Google Scholar]
  7. KERNELL D., SEDVALL G. REDUCTION OF THE NORADRENALINE CONTENT OF SKELETAL MUSCLE BY SYMPATHETIC STIMULATION. Acta Physiol Scand. 1964 May-Jun;61:201–202. doi: 10.1111/j.1748-1716.1964.tb02957.x. [DOI] [PubMed] [Google Scholar]
  8. KOPIN I. J., HERTTING G., GORDON E. K. Fate of norepinephrine-H3 in the isolated perfused rat heart. J Pharmacol Exp Ther. 1962 Oct;138:34–40. [PubMed] [Google Scholar]
  9. Lippmann W., Wishnick M. Effects of ethyl 3-acetamido-4H-pyrrolo[3,4-c]-isoxazole-5(6H)carboxylate on tissue levels of catecholamines and 5-hydroxytryptamine in the rat. J Pharm Pharmacol. 1967 Dec;19(12):855–856. doi: 10.1111/j.2042-7158.1967.tb09558.x. [DOI] [PubMed] [Google Scholar]
  10. Lippmann W., Wishnick M. Effects of the administration of epsilon amino caproic acid on catecholamine and serotonin levels in the rat and dog. J Pharmacol Exp Ther. 1965 Nov;150(2):196–202. [PubMed] [Google Scholar]
  11. MAYNERT E. W., KLINGMAN G. I. Tolerance to morphine. I. Effects on catecholamines in the brain and adrenal glands. J Pharmacol Exp Ther. 1962 Mar;135:285–295. [PubMed] [Google Scholar]
  12. MEAD J. A., FINGER K. F. A single extraction method for the determination of both norepinephrine and serotonin in brain. Biochem Pharmacol. 1961 Apr;6:52–53. doi: 10.1016/0006-2952(61)90069-7. [DOI] [PubMed] [Google Scholar]
  13. PAGE I. H., HURLEY R. E., DUSTAN H. P. The prolonged treatment of hypertension with guanethidine. JAMA. 1961 Feb 18;175:543–549. doi: 10.1001/jama.1961.03040070001001. [DOI] [PubMed] [Google Scholar]
  14. POTTER L. T., AXELROD J. PROPERTIES OF NOREPINEPHRINE STORAGE PARTICLES OF THE RAT HEART. J Pharmacol Exp Ther. 1963 Dec;142:299–305. [PubMed] [Google Scholar]
  15. RICHARDSON D. W., WYSO E. M. Effective reduction in blood pressure without ganglionic blockade. Va Med Mon (1918) 1959 Jul;86(7):377–381. [PubMed] [Google Scholar]
  16. SHORE P. A., OLIN J. S. Identification and chemical assay of norepinephrine in brain and other tissues. J Pharmacol Exp Ther. 1958 Mar;122(3):295–300. [PubMed] [Google Scholar]
  17. SPECTOR S., SJOERDSMA A., UDENFRIEND S. BLOCKADE OF ENDOGENOUS NOREPINEPHRINE SYNTHESIS BY ALPHA-METHYL-TYROSINE, AN INHIBITOR OF TYROSINE HYDROXYLASE. J Pharmacol Exp Ther. 1965 Jan;147:86–95. [PubMed] [Google Scholar]
  18. UDENFRIEND S., ZALTZMAN-NIRENBERG P. NOREPINEPHRINE AND 3,4DIHYDROXYPHENETHYLAMINE TURNOVER IN GUINEA PIG BRAIN IN VIVO. Science. 1963 Oct 18;142(3590):394–396. doi: 10.1126/science.142.3590.394. [DOI] [PubMed] [Google Scholar]
  19. WHITBY L. G., AXELROD J., WEIL-MALHERBE H. The fate of H3-norepinephrine in animals. J Pharmacol Exp Ther. 1961 May;132:193–201. [PubMed] [Google Scholar]
  20. Weissman A., Koe B. K. Behavioral effects of L-alpha-methyltyrosine, an inhibitor of tyrosine hydroxylase. Life Sci. 1965 May;4(10):1037–1048. doi: 10.1016/0024-3205(65)90223-7. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES